Monday, 21 Aug 2017

You are here

CDC Shows a 40% Lifetime Risk of Symptomatic Hand Osteoarthritis

Qin and colleagues have published in Arthritis & Rheumatology that 40% of people will be affected by symptomatic osteoarthritis in at least one hand.  (Citation source: http://buff.ly/2qTUscZ)  

They analyzed 2,218 adults ≥ 45 years from the Johnston County (NC) Osteoarthritis Project, specifically collecting looking for symptomatic hand OA (SHOA) over two time frames (1999-2004 and 2005-2010). SHOA was defined as having both self-reported symptoms and radiographic OA in the same hand.

The found the lifetime risk of SHOA is 39.8% with greater frequency in women as they age.  Women by age 85 yrs had a 47.2% frequency of SHOA compared to only 24.6% in men.

Hand OA was more common in whites moreso than blacks (41.4% vs 29.2%, respectively). The lifetime risk in the obese was 47.1 percent, compared to 36.1 percent for non-obese people.

Hand OA represents a significant publich health problem for which there are few, if any, credible treatment options.  Dr. Marc Hochberg and coworkers at OARSI have submitted a 103 page "white paper" to  FDA to designate OA as a "Serious Disease", staging that OA is a "serious disease for which there are no current satisfactory treatments". (Citation source: http://buff.ly/2pTuVm1)

 

Disclosures: 
The author has no conflicts of interest to disclose related to this subject

Add new comment

More Like This

Bad Knees Through the Ages

The average American today is twice as likely to be diagnosed with knee osteoarthritis as in the years before World War II, Harvard scientists say. And the reasons are less clear than you might think.

Based on a study of more than 2,000 skeletons from cadaveric and archaeological collections across the United States, a Harvard report is the first to definitively show that knee osteoarthritis prevalence has dramatically increased in recent decades.

Osteoporosis Care for RA Patients Found Suboptimal, Declining

Fewer than half of rheumatoid arthritis (RA) patients at a risk of fracture sufficient to warrant guideline-recommended osteoporosis treatment received appropriate care, according to a large study of U.S. osteoarthritis (OA) and RA patients.

Kids with Crohn's have Profound MSK Deficits - but No Increase in Fractures

Crohn’s disease (CD), a chronic inflammatory condition of the gastrointestinal tract, is also known for its propensity to affect the musculoskeletal system. Extraintestinal complications of CD include inflammatory polyarthritis, loss of muscle mass, growth retardation and vertebral compression fractures. Some of these are direct results of inflammation or indirect effects of malnutrition.

Joint Pain Linked to Increasing Temperature, Not Rainfall

Every rheumatologist knows and every rheumatic patient woes about the havoc weather inflicts on joint pains. Yet, research on this issue has seldom confirmed these impressions.  A novel new look has shown by linking online search terms with published weather conditions that increasing climate temperatures increased rates of hip and knee pain (searches), while precipitation had no effect.

Romosuzumab Outperforms Teriparatide in Post-Bisphosphonate Osteoporosis

The STRUCTURE trial results have been reported in Lancet and have shown that after 12 months of therapy, romosozumab (ROMO) had superior gains in bone mineral density (BMD) compared to teriparatide (TER) in women with postmenopausal osteoporosis who have previously taken bisphosphonate therapy.